spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Wickham Laboratories Announces Upcoming Webinar on In-Vitro Alternatives

Wickham Laboratories Limited

Join us for a free webinar to discuss the challenges of transitioning from in-vivo to in-vitro methods

We would like to invite you to our latest webinar, “The Push for In-Vitro Alternatives in Toxicology: Understanding the Process Behind Developing Alternative Safety Testing”, which will take place on 29th June at 3PM London / 10 AM New York.

During this webinar, our technical experts will discuss the importance of understanding the process and complications involved in the development and validation of in-vitro alternatives including a case study where the limitations of various methods are considered. We hope that you will be able to join us on 29th June for this engaging topic and look forward to discussing questions regarding the development process in the open Q&A session afterward.

Registration is now open and you can access this and more details about the webinar content via our online landing page located here.

Company Overview

As a GMP/GLP compliant laboratory with over 50 years of experience, Wickham Laboratories Ltd is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. We conduct business with clients worldwide and the combined expertise of our laboratory technicians and managers enables us to be fully conversant with global regulatory expectations.

We are committed to providing a quality testing service, combining high levels of client satisfaction together with the maintenance of appropriate accreditation. This and the continual pursuit of delivering excellence remain central to our business.

We are routinely inspected by the MHRA, FDA and Home Office, and offer the opportunity for clients to conduct audits on a regular basis.

For more information about Wickham Laboratories Limited and our services, please contact us at +44 (0)1329 226600 or mail@wickhamlabs.co.uk. To directly request a company brochure, please visit the Brochure section of our company website.

phone +44 (0)1329 226600
email marketing@wickhamlabs.co.uk
web www.wickhamlabs.co.uk/
email Hoeford Point, Barwell Lane, Gosport, Hampshire, PO13 0AU, United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>


White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

Industry Events

Adaptive Designs in Clinical Trials

9-10 April 2018, Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK

Now running for 10 years, SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 9thand 10th April 2018. This year’s agenda has been curated to provide you with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement